Last $7.25 USD
Change Today -0.095 / -1.29%
Volume 6.1M
PGNX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Mendelsohn M.D.

Member of Cancer Scientific Advisory Board, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 166 board members in 5 different organizations across 6 different industries.

See Board Relationships
77--

Background*

Dr. John Mendelsohn, M.D., serves as a Director of Greater Houston Partnership. Dr. Mendelsohn has been a Director at Merrimack Pharmaceuticals, Inc. since June 18, 2012. He is the Co-Director of the Sheik Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy. Dr. Mendelsohn is an internationally recognized leader in cancer research and cancer therapy. He was the President of The University of Texas M. D. Anderson Cancer Center. Dr. Mendelsohn served ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

Former Director
Director and Member of Executive Committee
1998-N/A
Former Member of Board of Directors
2012-Present
Director and Member of Organization & Compensation Committee

Education*

Bachelor's Degree 1958
Harvard College
MD 1963
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $7.25 USD -0.095

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.